Literature DB >> 16907815

In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis-associated bacteria.

F Atassi1, D Brassart, P Grob, F Graf, A L Servin.   

Abstract

AIMS: The purpose of this study was to investigate in vitro the antibacterial activity of the Lactobacillus helveticus strain KS300 against vaginosis-associated bacteria including Gardnerella vaginalis and Prevotella bivia, uropathogenic Escherichia coli, and diarrhoeagenic Salmonella enterica serovar Typhimurium. METHODS AND
RESULTS: The KS300 strain inhibited the growth of G. vaginalis, P. bivia, S. typhimurium, and pathogenic E. coli. After direct co-culture, data show that the Lactobacillus strain decreased the viability of G. vaginalis, P. bivia, S. typhimurium, and pathogenic E. coli. The adhering KS300 strain inhibited the adhesion of G. vaginalis DSM 4944 and uropathogenic Dr-positive E. coli IH11128 onto HeLa cells. Moreover, the KS300 strain inhibited the internalization of uropathogenic Dr-positive E. coli IH11128 within HeLa cells and S. typhimurium SL1344 within Caco-2/TC7 cells.
CONCLUSIONS: The findings demonstrate that L. helveticus strain KS300 is adhesive onto cultured human cells and has antagonistic activities against vaginosis-associated, uropathogenic and diarrhoeagenic pathogens. SIGNIFICANCE AND IMPACT OF THE STUDY: Adhering L. helveticus strain KS300 is a potential probiotic strain displaying a strain-specific array of in vitro antibacterial activities.

Entities:  

Mesh:

Year:  2006        PMID: 16907815     DOI: 10.1111/j.1365-2672.2006.02933.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  9 in total

Review 1.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

2.  Purification and characterization of pediocin from probiotic Pediococcus pentosaceus GS4, MTCC 12683.

Authors:  Budhaditya Ghosh; Gowri Sukumar; Asit Ranjan Ghosh
Journal:  Folia Microbiol (Praha)       Date:  2019-02-22       Impact factor: 2.099

3.  Evaluation of Lactobacilli for Antagonistic Activity Against the Growth, Adhesion and Invasion of Klebsiella pneumoniae and Gardnerella vaginalis.

Authors:  Cheng-Chih Tsai; Tzu-Min Lai; You-Miin Hsieh
Journal:  Indian J Microbiol       Date:  2018-07-27       Impact factor: 2.461

4.  Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial.

Authors:  Alessandra Pino; Giuliana Giunta; Cinzia L Randazzo; Salvatore Caruso; Cinzia Caggia; Antonio Cianci
Journal:  Microb Ecol Health Dis       Date:  2017-01-01

5.  Lactobacilli enhance reactive oxygen species-dependent apoptosis-inducing signaling.

Authors:  Hannah Krüger; Georg Bauer
Journal:  Redox Biol       Date:  2017-01-24       Impact factor: 11.799

6.  Types and viral load of human papillomavirus, and vaginal microbiota in vaginal intraepithelial neoplasia: a cross-sectional study.

Authors:  Fang-Yue Zhou; Qi Zhou; Zhong-Yi Zhu; Ke-Qin Hua; Li-Mei Chen; Jing-Xin Ding
Journal:  Ann Transl Med       Date:  2020-11

7.  Health-Promoting Properties of Lactobacillus helveticus.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Front Microbiol       Date:  2012-11-19       Impact factor: 5.640

8.  Technological and probiotic potential of BGRA43 a natural isolate of Lactobacillus helveticus.

Authors:  Ivana Strahinic; Jelena Lozo; Amarela Terzic-Vidojevic; Djordje Fira; Milan Kojic; Natasa Golic; Jelena Begovic; Ljubisa Topisirovic
Journal:  Front Microbiol       Date:  2013-01-23       Impact factor: 5.640

9.  The protective effects of enriched citrulline fermented milk with Lactobacillus helveticus on the intestinal epithelium integrity against Escherichia coli infection.

Authors:  Sze Wing Ho; Hani El-Nezami; Nagendra P Shah
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.